-2%
Diasulin R 100 IU/ml Injection (Human Insulin rDNA)
Diabetes Mellitus (Type 1 and Type 2)
Diabetic Ketoacidosis (DKA)
Hyperkalemia (as adjunct therapy with glucose infusion)
Diasulin R (Regular Human Insulin) is a short-acting insulin that regulates carbohydrate, protein, and fat metabolism.
It reduces blood glucose by:
- Promoting glucose uptake in muscle and adipose tissues
- Suppressing hepatic glucose production
- Inhibiting lipolysis and proteolysis
It has a rapid onset (30 minutes), peak effect at 1–3 hours, and duration of 6–8 hours.
Intravenous administration produces immediate glucose-lowering effects, while subcutaneous absorption is slower.